Leading catheter company fights negligence claims in federal trial
C.R. Bard developed an antimicrobial port catheter intended to reduce infection rates but never received FDA clearance.
Original Source
Read the full article at Courthousenews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.